The patient asks the nurse what atorvastatin (Lipitor) newly prescribed will do. What's the expected outcome the nurse will describe?
Decrease in sitosterol and serum cholesterol.
Decrease in campesterol and LDL levels.
Decrease in serum cholesterol and low-density lipoprotein (LDL) levels.
Decrease in serum cholesterol only.
The Correct Answer is C
Choice A rationale
Atorvastatin (Lipitor) does not decrease sitosterol. It mainly targets serum cholesterol and LDL levels to reduce cardiovascular risks.
Choice B rationale
Atorvastatin does not decrease campesterol. Its primary effect is on serum cholesterol and LDL levels, aiming to lower the risk of heart disease.
Choice C rationale
Atorvastatin effectively decreases serum cholesterol and LDL levels, which are the primary targets for reducing cardiovascular risks in patients with high cholesterol.
Choice D rationale
Atorvastatin lowers both serum cholesterol and LDL levels, not just serum cholesterol, making it effective in reducing overall cardiovascular risk.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["C","D","E"]
Explanation
Choice A rationale
Analyzing data collected is part of the assessment phase, not the intervention phase.
Choice B rationale
Collecting a nursing history is part of the assessment phase of the nursing process, not the intervention phase.
Choice C rationale
Determining medication effectiveness is a critical aspect of the intervention phase, as it assesses the therapeutic outcomes of the administered drugs.
Choice D rationale
Documenting the medication is a key action in the intervention phase to ensure accurate and up-to-date patient records and safe administration.
Choice E rationale
Administering the medication is a direct intervention related to drug therapy and is part of the intervention phase.
Correct Answer is A
Explanation
Choice A rationale
Sumatriptan (Imitrex) is a selective serotonin receptor agonist that helps constrict blood vessels in the brain and is typically used to treat migraine and cluster headaches. Its effectiveness is due to its ability to reduce inflammation and alleviate the pain associated with these headaches.
Choice B rationale
Naratriptan (Amerge) is also a triptan used for the treatment of migraines but is not specifically indicated for cluster headaches.
Choice C rationale
Frovatriptan (Frova) is used mainly for the acute treatment of migraine headaches and is not indicated for cluster headaches.
Choice D rationale
Almotriptan (Axert) is used to treat migraines and does not have an indication for cluster headaches.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
